Free Trial

Outset Medical (OM) Competitors

Outset Medical logo
$12.45 -2.66 (-17.60%)
Closing price 04:00 PM Eastern
Extended Trading
$12.46 +0.01 (+0.04%)
As of 06:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OM vs. TNDM, INMD, BBNX, IRMD, EMBC, AXGN, CLPT, BFLY, SIBN, and BVS

Should you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include Tandem Diabetes Care (TNDM), InMode (INMD), Beta Bionics (BBNX), iRadimed (IRMD), Embecta (EMBC), AxoGen (AXGN), ClearPoint Neuro (CLPT), Butterfly Network (BFLY), SiBone (SIBN), and Bioventus (BVS). These companies are all part of the "medical equipment" industry.

Outset Medical vs. Its Competitors

Outset Medical (NASDAQ:OM) and Tandem Diabetes Care (NASDAQ:TNDM) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

Tandem Diabetes Care has higher revenue and earnings than Outset Medical. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$113.69M1.95-$127.98M-$20.29-0.61
Tandem Diabetes Care$940.20M1.01-$96.03M-$3.09-4.53

Outset Medical has a beta of 2.13, indicating that its stock price is 113% more volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.48, indicating that its stock price is 48% more volatile than the S&P 500.

In the previous week, Tandem Diabetes Care had 6 more articles in the media than Outset Medical. MarketBeat recorded 9 mentions for Tandem Diabetes Care and 3 mentions for Outset Medical. Tandem Diabetes Care's average media sentiment score of 0.88 beat Outset Medical's score of 0.83 indicating that Tandem Diabetes Care is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Outset Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tandem Diabetes Care
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Outset Medical presently has a consensus target price of $24.67, suggesting a potential upside of 98.13%. Tandem Diabetes Care has a consensus target price of $22.69, suggesting a potential upside of 62.05%. Given Outset Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe Outset Medical is more favorable than Tandem Diabetes Care.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
Tandem Diabetes Care
1 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.24

Tandem Diabetes Care has a net margin of -20.51% compared to Outset Medical's net margin of -82.06%. Tandem Diabetes Care's return on equity of -65.40% beat Outset Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical-82.06% -97.17% -32.84%
Tandem Diabetes Care -20.51%-65.40%-13.87%

Summary

Tandem Diabetes Care beats Outset Medical on 9 of the 15 factors compared between the two stocks.

Get Outset Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OM vs. The Competition

MetricOutset MedicalMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$268.45M$2.30B$6.11B$10.63B
Dividend YieldN/AN/A5.66%4.71%
P/E Ratio-0.6137.4685.2726.57
Price / Sales1.9512.29612.79132.68
Price / CashN/A63.0138.5062.09
Price / Book1.6612.9512.726.53
Net Income-$127.98M-$63.46M$3.30B$275.96M
7 Day Performance-14.08%-2.84%1.05%-1.40%
1 Month Performance-8.05%3.72%7.56%5.16%
1 Year Performance36.18%41.33%79.69%31.55%

Outset Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OM
Outset Medical
1.9457 of 5 stars
$12.45
-17.6%
$24.67
+98.1%
+59.9%$268.45M$113.69M-0.61520News Coverage
Analyst Forecast
High Trading Volume
TNDM
Tandem Diabetes Care
4.1898 of 5 stars
$15.12
+0.7%
$22.44
+48.4%
-62.1%$1.02B$940.20M-4.892,650Analyst Forecast
INMD
InMode
2.8663 of 5 stars
$15.28
+0.3%
$18.04
+18.1%
+5.6%$967.30M$394.82M6.20480Trending News
Analyst Forecast
BBNX
Beta Bionics
2.3349 of 5 stars
$21.80
-0.7%
$24.44
+12.1%
N/A$947.65M$65.12M0.00294Analyst Forecast
Insider Trade
IRMD
iRadimed
4.5852 of 5 stars
$72.38
+0.9%
$72.00
-0.5%
+52.7%$919.99M$77.64M44.66110Analyst Forecast
Insider Trade
EMBC
Embecta
4.6682 of 5 stars
$14.07
-0.8%
$19.00
+35.0%
+4.1%$827.63M$1.12B9.902,100News Coverage
Positive News
Analyst Downgrade
AXGN
AxoGen
2.9967 of 5 stars
$17.29
+0.8%
$25.75
+48.9%
+19.6%$792.75M$187.34M-172.28450Analyst Forecast
CLPT
ClearPoint Neuro
0.5896 of 5 stars
$26.70
+0.4%
$19.67
-26.3%
+138.7%$758.94M$31.39M-32.96110Analyst Forecast
BFLY
Butterfly Network
2.9977 of 5 stars
$2.49
-2.9%
$3.00
+20.7%
+35.2%$635.64M$82.06M-9.02460News Coverage
Analyst Forecast
SIBN
SiBone
3.888 of 5 stars
$14.55
+0.4%
$23.67
+62.6%
+22.4%$627.87M$185.26M-25.99350Analyst Forecast
BVS
Bioventus
1.3267 of 5 stars
$6.71
-1.2%
N/AN/A$554.78M$573.28M14.041,200News Coverage
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:OM) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners